Fibroblast growth factor 21 corrects obesity in mice.
暂无分享,去创建一个
D. Moller | Yanyun Chen | T. Coşkun | A. Kharitonenkov | Holly A. Bina | Michael A Schneider | H. Bina | J. Dunbar | Charlie C. Hu | T. Coskun
[1] Masashi Suzuki,et al. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. , 2008, Molecular endocrinology.
[2] J. D. Dunbar,et al. FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho , 2008, Journal of cellular physiology.
[3] W. Pan,et al. The fasting polypeptide FGF21 can enter brain from blood , 2007, Peptides.
[4] L. Qiang,et al. Identification of a Domain within Peroxisome Proliferator-Activated Receptor γ Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in Adipocytes , 2007, Molecular and Cellular Biology.
[5] T. Lundåsen,et al. PPARα is a key regulator of hepatic FGF21 , 2007 .
[6] S. Kliewer,et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. , 2007, Cell metabolism.
[7] J. Flier,et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. , 2007, Cell metabolism.
[8] K. Rosenblatt,et al. βKlotho is required for metabolic activity of fibroblast growth factor 21 , 2007, Proceedings of the National Academy of Sciences.
[9] Yun-Fei Chen,et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. , 2007, Endocrinology.
[10] F. Mehrbod,et al. Molecular determinants of FGF‐21 activity—synergy and cross‐talk with PPARγ signaling , 2007, Journal of cellular physiology.
[11] W. Mckeehan,et al. Forced expression of hepatocyte‐specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis , 2006, Molecular carcinogenesis.
[12] J. Gromada,et al. Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways , 2006, Diabetes.
[13] B. Spiegelman,et al. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. , 2006, Endocrine reviews.
[14] J. Auwerx,et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.
[15] Y. Nabeshima,et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. , 2005, The Journal of clinical investigation.
[16] A. Dobrzyń,et al. The role of stearoyl-CoA desaturase in the control of metabolism. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[17] J. Gromada,et al. FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.
[18] V. P. Eswarakumar,et al. Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.
[19] M. Stoffel,et al. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes , 2004, Nature.
[20] L. Rossetti,et al. Minireview: nutrient sensing and the regulation of insulin action and energy balance. , 2003, Endocrinology.
[21] N. Socci,et al. Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss , 2002, Science.
[22] D. Moller,et al. New drug targets for type 2 diabetes and the metabolic syndrome , 2001, Nature.
[23] G I Bell,et al. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.
[24] Y. Nabeshima,et al. Molecular cloning and expression analyses of mouse βklotho, which encodes a novel Klotho family protein , 2000, Mechanisms of Development.
[25] M. Konishi,et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. , 2000, Biochimica et biophysica acta.